Administration of Brincidofovir and Convalescent Plasma in a Patient with Ebola Virus Disease

Diana F. Florescu, Andre C. Kalil, Angela L. Hewlett, Amy J. Schuh, Ute Stroher, Timothy M. Uyeki, Philip W. Smith

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.

Original languageEnglish (US)
Pages (from-to)969-973
Number of pages5
JournalClinical Infectious Diseases
Volume61
Issue number6
DOIs
StatePublished - Jun 8 2015

Keywords

  • Ebola
  • investigational therapies
  • trials

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Administration of Brincidofovir and Convalescent Plasma in a Patient with Ebola Virus Disease'. Together they form a unique fingerprint.

  • Cite this